Cited by 82Obstructive Sleep Apnea ResearchBlood Coagulation and Thrombosis MechanismsSleep and related disorders

Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study

Open access
Phillips, Craig L, McEwen, Bradley J, Morel-Kopp, Marie-Christine, Yee, Brendon J, Sullivan, David R, Ward, Christopher M, Tofler, Geoffrey H, Grunstein, Ronald R·2012·Thorax

Abstract

INTRODUCTION: Obstructive sleep apnoea (OSA) is associated with increased cardiovascular risk, however the mechanisms are not well established. OBJECTIVES: This study aimed to determine whether treatment of OSA with nasal continuous positive airway pressure (CPAP) would favourably alter coagulability across the sleep-wake cycle. METHODS: In a randomised crossover trial, 28 patients received therapeutic or placebo CPAP, each for 2 months with a 1 month washout between treatments. After each treatment period, a 24 h coagulation study was conducted in the laboratory. Plasminogen activator inhibitor-1 (PAI-1), D-dimer, fibrinogen, von Willebrand Factor (vWF), factor VIII (FVIII), factor VII (FVII) and factor V (FV) were determined at seven time points over the day and night. RESULTS: At baseline, patients had severe OSA (Apnoea Hypopnoea Index 37.9 ± 23.9 events/h). Treatment of OSA with CPAP compared with placebo resulted in lower 24 h levels of vWF (-3.9%, p=0.013), FVIII (-6.2%, p=0.007) and FV (-4.2%, p<0.001). The greatest difference occurred during the nocturnal and early morning periods. In contrast, fibrinogen, D-dimer, FVII and PAI-1 did not differ between treatments, however all markers displayed diurnal variability independent of treatment. CONCLUSIONS: In this randomised, placebo-controlled crossover trial, treatment of OSA with CPAP reduced the early morning level of vWF, and nocturnal levels of FVIII and FV. These findings suggest that CPAP may reduce cardiovascular risk in OSA, in part through reducing risk of thrombosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/thoraxjnl-2011-200874

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Possible pathophysiologic mechanisms linking OSA to myocardial ischemia include sympathetic nervous system hyperactivity, hypertension, endothelial dysfunction, metabolic dysregulation, insulin resistance, and a hypercoagulable state.

    “A number of possible pathophysiologic mechanisms have been implicated including sympathetic nervous system hyperactivity, hypertension, endothelial dysfunction, metabolic dysregulation, insulin resistance, and hypercoagulable state.641,655–663”

    From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [661]

    The Discussion says hypertension, endothelial dysfunction and increased coagulation in OSA may contribute to cardiovascular events, and it links coagulation markers to myocardial infarction. The cited paper does not address sympathetic nervous system hyperactivity, metabolic dysregulation or insulin resistance as mechanisms, so it supports only part of the list. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [1]1. Thorax 2012;67:639e644. doi:10.1136/thoraxjnl-2011-200874 Sleep disordered breathing on July 23, 2023 by guest. Protected by copyright. http://thorax.bmj.com/ Thorax: first published as 10.1136/thoraxjnl-2011-200874 on 14 February 2012. Downloaded from REFERENCES

Cited by

Sorted by citations

Authors
Phillips, C. L., McEwen, B. J., Morel-Kopp, M.-C., Yee, B. J., Sullivan, D. R., Ward, C. M., Tofler, G. H., & Grunstein, R. R.
Affiliations
  • The University of Sydney (AU)
  • Royal Prince Alfred Hospital (AU)
  • Royal North Shore Hospital (AU)
Corresponding author
Phillips, Craig L
Venue
Thorax
Publisher
BMJ
Published
2012-02-14
Volume
67
Issue
7
Pages
639-644
ISSN
  • 0040-6376 (ISSN-L)
  • 1468-3296
OpenAlex
W2118630296
Cited by
82
References
55
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 9 · 2021: 12 · 2020: 5 · 2019: 7 · 2018: 5 · 2017: 3 · 2016: 5 · 2015: 10 · 2014: 9 · 2013: 4 · 2012: 4
FWCI
5.79
Type
journal article
Language
en
Open access
Locations
  • Thorax (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
obstructive sleep apnea, continuous positive airway pressure, coagulability, von Willebrand factor, factor VIII, factor V, fibrinogen, D-dimer, plasminogen activator inhibitor-1, diurnal variation, thrombosis risk, cardiovascular risk
MeSH terms
Blood Coagulation, Female, Fibrin Fibrinogen Degradation Products, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, von Willebrand Factor, Treatment Outcome, Plasminogen Activator Inhibitor 1, Cross-Over Studies, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review